olaparib,abiraterone,talazoparib,enzalutamide
merck,astellas,astrazeneca,pfizer
['talapro2', 'crpc', 'propel', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
both propel and talapro2 show modest rpfs benefit (no os benefit so far) in patients with hrr-wt mcrpc. is it enough to justify toxicity and cost? jury is still out. combo approved in europe but not in us. #gu23 
Genitourinary medical oncologist at UNC Lineberger Cancer Center, husband of @SarahRoMD, father, person of faith, Tar Heel fan, PhD in virology